BioNetwork Training

The BioNetwork Capstone Center provides affordable, high-quality, hands-on training in biotechnology, biomanufacturing, and biopharmaceutical/pharmaceutical operations in a simulated industrial (cGMP) environment.

The Capstone Center is situated in the Golden LEAF Biomanufacturing Training and Education Center (BTEC) at North Carolina State University Centennial Campus. It provides a training environment that mirrors a biomanufacturing plant facility with state-of-the-art classrooms, industrial-grade equipment laboratories, and a certified cleanroom suite.

Industry-recognized credential: BioNetwork Capstone Certificates

Complete in: 12 months or less

For non-credit student support services or to see if you qualify for financial assistance, contact the Career Pathways Program & Student Resources. 

Get Support


Course Details & Registration Information

Fundamentals of Validation
Available Classes
    Section Location Begin Date End Date Instructor Price Seats Available/Total Seats
199265 BTEC BioNetwork Capstone Learning Center 11/09/2018 11/09/2018 R. Fernandez $125.00 5/20
Description Course Outline Requirements Intended Audience More Details
This course is designed to introduce technicians and professionals to the principles and regulatory requirements of current drug, biologic and medical product validation.
Course Objectives
  1. Understand the motivation and purpose of medical product validation.
  2. Understand the difference between "qualification" and "validation" practices.
  3. Be orientated and become familiar with requirements of the 2011 FDA Guidance to Industry "Process Validation: General Principles and Practices" and EudraLex Vol. 4 Annex 15 "Qualification and Validation".
Outline of Instruction
  1. Introduction: factors precipitating FDA’s validation concept and approach
  2. Foundational concepts and approaches established by FDA’s 1987 “Guideline on General Principles of Process Validation”
  3. Medial device validation - the “Design Control” approach
  4. The influence and impact of modern cGMPs on validation
  5. Validation principles updated by the 2011 FDA Guidance to Industry “Process Validation: General Principles and Practices”
  6. Compare and contrast the 011 FDA Guidance to Industry “Process Validation: General Principles and Practices” with the 2015 EudraLex Vol. 4 Annex 15 “Qualification and Validation” Guideline
  7. The regulatory basis for drug and medical device validation requirements
Contact Hours
Industry Standard, State, or National Certification
CE to CU Articulation
Text and Supplies Needed
Clinical Site/Special Facilities
Requirements for Successful Completion of this Course
  1. Attendance 80% or above
  2. Participation
Accreditation/Special Approval Requirements
Intended Audience
Specific Industry or Business Support Needs
Industry or Job Titles Related to training Outcomes for Employment
Related Courses
Course Contact Information
Bionetwork Manager